Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that it has selected Pisgah Laboratories' abuse-deterrent technology platform as one of its Top 5 Technologies To Reduce Prescription Drug Abuse.
Pisgah Laboratories' lead abuse-deterrent technology product candidate Hydrocodone/APAP, is intended to provide relief to patients in need of treatment, yet lessen the potential for drug abuse.
According to Bill Bristol, the company's founder and CEO, "Employing organic chemistry, Pisgah's technology addresses prescription drug abuse at the core of the demand, a product's active ingredient. We're grateful for CLAAD's recognition of our innovation."
The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.
Michael Barnes, spokesman for CLAAD, stated, "We support Pisgah's efforts to develop novel medications to advance patient care and simultaneously inhibit abuse."
San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.
"We are proud to recognize Pisgah Laboratories for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories.
About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care. CLAAD's National Prescription Drug Abuse Prevention Strategy, which has earned the endorsements of 30 non-profit organizations, identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy. Visit claad.org, and follow @claad_coalition.
About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety.
About Pisgah Laboratories, Inc.
Pisgah Laboratories is uniquely positioned to help fill empty product pipelines with a host of abuse-deterrent pain management products which are patent protected and offer performance-enhancing benefits. For licensing or product development opportunities, please contact Todd Stamps at 803-212-8224 for additional information.
More by this Source
CLAAD Lauds Signature Therapeutics' R&D Efforts To Reduce Prescription Drug Abuse
Jul 12, 2013, 12:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.